BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Allergy to pollen
,
Intestine
,
Neocentromeres
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SRF_Q4
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Aorta
Saphenous vein
Vena cava
Myometrium
Urethra
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Alpha-1-antitrypsin deficiency
Vesicular stomatitis Indiana virus disease
Barrett's esophagus
Esophagitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CGP 60474
A 443654
flavopiridol
OTS-167
Pluronic F68
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TLK2
FUBP3
NOP2
NR5A1
NCL
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
PBMC microRNA expression from pulmonary tuberculosis and sarcoidosis patients
Follicular fluid miRNA profiles during the development of the oocyte
Lung adenocarcinoma and adjacent normal tissue miRNA expression profiles
miRNA expression profiles from osteosarcoma samples and cell lines
Kidneys from male C57BL6 mice 28 days after left proximal ureter ligations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for SRF_Q4
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-rela…
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg D…
Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Re…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ